Kljun et al., 2013 - Google Patents
New uses for old drugs: attempts to convert quinolone antibacterials into potential anticancer agents containing rutheniumKljun et al., 2013
View PDF- Document ID
- 11706945240714283289
- Author
- Kljun J
- Bratsos I
- Alessio E
- Psomas G
- Repnik U
- Butinar M
- Turk B
- Turel I
- Publication year
- Publication venue
- Inorganic chemistry
External Links
Snippet
Continuing the study of the physicochemical and biological properties of ruthenium- quinolone adducts, four novel complexes with the general formula [Ru ([9] aneS3)(dmso- κS)(quinolonato-κ 2 O, O)](PF6), containing the quinolones levofloxacin (1), nalidixic acid …
- 239000003814 drug 0 title description 34
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
- C07F15/0086—Platinum compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
- C07F15/0073—Rhodium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P-C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F17/00—Metallocenes
- C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kljun et al. | New uses for old drugs: attempts to convert quinolone antibacterials into potential anticancer agents containing ruthenium | |
| Carrasco et al. | Structurally strained half-sandwich iridium (III) complexes as highly potent anticancer agents | |
| Kljun et al. | Physicochemical studies and anticancer potency of ruthenium η6-p-cymene complexes containing antibacterial quinolones | |
| Yang et al. | Novel and versatile imine-N-heterocyclic carbene half-sandwich iridium (III) complexes as lysosome-targeted anticancer agents | |
| Haribabu et al. | Water-soluble mono-and binuclear Ru (η6-p-cymene) complexes containing indole thiosemicarbazones: Synthesis, DFT modeling, biomolecular interactions, and in vitro anticancer activity through apoptosis | |
| Kubanik et al. | Impact of the halogen substitution pattern on the biological activity of organoruthenium 8-hydroxyquinoline anticancer agents | |
| Rilak et al. | New water-soluble ruthenium (II) terpyridine complexes for anticancer activity: synthesis, characterization, activation kinetics, and interaction with guanine derivatives | |
| Turel et al. | First ruthenium organometallic complex of antibacterial agent ofloxacin. Crystal structure and interactions with DNA | |
| Martinez-Alonso et al. | Derivation of structure–activity relationships from the anticancer properties of ruthenium (II) arene complexes with 2-aryldiazole ligands | |
| Caruso et al. | Ruthenium–arene complexes of curcumin: X-ray and density functional theory structure, synthesis, and spectroscopic characterization, in vitro antitumor activity, and DNA docking studies of (p-cymene) Ru (curcuminato) chloro | |
| Zhong et al. | A rhodium (III) complex as an inhibitor of neural precursor cell expressed, developmentally down-regulated 8-activating enzyme with in vivo activity against inflammatory bowel disease | |
| Boselli et al. | Synthesis, structures, and biological studies of heterobimetallic Au (I)–Ru (II) complexes involving N-heterocyclic carbene-based multidentate ligands | |
| van Rijt et al. | Cytotoxicity, hydrophobicity, uptake, and distribution of osmium (II) anticancer complexes in ovarian cancer cells | |
| Frik et al. | In vitro and in vivo evaluation of water-soluble iminophosphorane ruthenium (II) compounds. A potential chemotherapeutic agent for triple negative breast cancer | |
| Gumus et al. | Synthesis, cytotoxicity, and DNA interactions of new cisplatin analogues containing substituted benzimidazole ligands | |
| Palmucci et al. | Synthesis, structure, and anticancer activity of arene–ruthenium (II) complexes with acylpyrazolones bearing aliphatic groups in the acyl moiety | |
| Chauhan et al. | DNA binding studies of novel copper (II) complexes containing l-tryptophan as chiral auxiliary: in vitro antitumor activity of Cu− Sn2 complex in human neuroblastoma cells | |
| Ginzinger et al. | A SAR study of novel antiproliferative ruthenium and osmium complexes with quinoxalinone ligands in human cancer cell lines | |
| Kalaivani et al. | Versatile coordination behavior of salicylaldehydethiosemicarbazone in ruthenium (II) carbonyl Complexes: synthesis, spectral, X-ray, electrochemistry, DNA binding, cytotoxicity, and cellular uptake studies | |
| Grote et al. | pH-triggered assembly of organometallic receptors for lithium ions | |
| Mendoza-Ferri et al. | Influence of the spacer length on the in vitro anticancer activity of dinuclear Ruthenium− Arene compounds | |
| Ruiz et al. | Novel bis-C, N-cyclometalated iridium (III) thiosemicarbazide antitumor complexes: Interactions with human serum albumin and DNA, and inhibition of cathepsin B | |
| Mattsson et al. | Synthesis, molecular structure, and anticancer activity of cationic arene ruthenium metallarectangles | |
| Pettinari et al. | Arene–ruthenium (II) acylpyrazolonato complexes: apoptosis-promoting effects on human cancer cells | |
| Mendoza-Ferri et al. | Influence of the arene ligand, the number and type of metal centers, and the leaving group on the in vitro antitumor activity of polynuclear organometallic compounds |